CEFEPIME HCL 2 GRAM VIAL
CEFEPIME HCL 2 GRAM VIAL, a generic antibiotic with a $5.35 acquisition cost, often shows significant pricing variations between acquisition costs and hospital billing rates.
About the analyst
Kevin Nyk analyzes hospital pricing data at BillRazor Research. He specializes in Medicare reimbursement patterns and chargemaster pricing across U.S. hospitals. Expertise: hospital pricing, Medicare rates, chargemaster analysis.
Cefepime HCL is a fourth-generation cephalosporin antibiotic used to treat serious bacterial infections including pneumonia, urinary tract infections, and skin infections. This generic injectable antibiotic typically requires prior authorization for outpatient use and may have significantly different reimbursement rates between inpatient and outpatient settings.
No credit card required. Results in 60 seconds.
Common billing errors — Antibiotics charges
Antibiotic billing errors frequently involve substantial charges above the benchmark, with hospital markups ranging from 200-800% over the $3.05 average NADAC acquisition cost. Common duplicate billing occurs when patients receive both brand-name antibiotics like Zithromax and their generic equivalents such as azithromycin on the same statement, creating potential differences of $15-50 per duplicate entry. Generic substitution discrepancies appear when hospitals bill for expensive brand formulations but actually dispense generic versions, with potential differences reaching $25-75 per medication. IV-to-oral conversion billing represents another frequent issue, where patients continue being charged for intravenous antibiotic administration fees after switching to oral forms of the same medication. Additionally, dosing calculation errors often result in charges for antibiotic quantities that exceed prescribed amounts, particularly with liquid formulations where billing systems may round up to full vial quantities regardless of actual usage.
What to check on your bill
When reviewing antibiotic charges on your hospital bill, examine the medication administration section for specific drug names, dosages, and frequency. Look for line items showing "IV push," "IV piggyback," or "oral administration" fees, which may appear separately from the drug cost itself. Check if generic antibiotics like ceftriaxone or azithromycin show charges above the benchmark compared to brand names. Verify that the number of doses billed matches your actual treatment days - a 7-day course should not show 10-12 doses unless medically documented. Review pharmacy preparation fees, particularly for IV antibiotics requiring reconstitution or special mixing. Compare similar antibiotic classifications on your bill, as therapeutic equivalents can show significant cost differences. Examine any "stat dose" or "urgent preparation" charges, which typically cost more than routine scheduled medications. Look for duplicate entries where the same antibiotic appears under different service codes or departments. Cross-reference antibiotic start and stop dates with your medical records to identify any potential difference in billing periods versus actual treatment duration.
FAQ — Antibiotics billing
What is the average acquisition cost for antibiotic medications?
How many different antibiotic drugs are included in standard billing classifications?
How should billing departments handle charges above the NADAC benchmark for antibiotics?
What billing considerations apply when processing antibiotic prescription claims?
Related pricing data
Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.
What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.
Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.